Relative effectiveness and cost-effectiveness of methods of androgen suppression in the treatment of advanced prostate cancer

Author(s)

• Aronson, Naomi
• United States. Agency for Health Care Policy and Research
• Blue Cross and Blue Shield Association

Bibliographic Information

Relative effectiveness and cost-effectiveness of methods of androgen suppression in the treatment of advanced prostate cancer

prepared for Agency for Health Care Policy and Research ; prepared by Blue Cross and Blue Shield Association, Naomi Aronson ... [et al.]

（Evidence report/technology assessment, no. 4）（AHCPR pub., no. 99-E0012）

U.S. Dept. of Health and Human Services, Public Health Service, Agency for Health Care Policy and Research, 1999

Other Title

Relative effectiveness and cost-effectiveness of methods of androgen suppression in the treatment of advanced prostatic cancer

Note

"May 1999."

Available via Internet from the National Library of Medicine web site. Address as of 10/2/01: http://hstat.nlm.nih.gov/ftrs/pick?collect=epc&dbName=prost&cd=1&t=1002035486; current access is available via PURL

Includes bibliographical references

"Contract no. 290-97-0015."

• NCID: BA56284336
• Country Code: us
• Title Language Code: eng
• Text Language Code: eng
• Place of Publication: Rockville, Md.
• Pages/Volumes: 1 v. (various pagings)
• Size: 28 cm
• Subject Headings:
  • LCSH : Prostate -- Cancer -- Hormone therapy
  • LCSH : Antiandrogens -- Therapeutic use
  • MESH : Prostatic Neoplasms -- drug therapy
  • MESH : Antineoplastic Agents, Hormonal -- therapeutic use
  • MESH : Cost-Benefit Analysis
  • MESH : Gonadorelin -- agonists
  • MESH : Treatment Outcome
  • FREE : Meta-Analysis. mesh
• Parent Bibliography ID:
  • BA56237777
  • BA24086693